New Zealand markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
479.06+7.98 (+1.69%)
As of 02:40PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 39.56B
Enterprise value 40.38B
Trailing P/E 53.50
Forward P/E 52.08
PEG ratio (5-yr expected) 4.63
Price/sales (ttm)12.91
Price/book (mrq)52.41
Enterprise value/revenue 12.88
Enterprise value/EBITDA 39.59

Trading information

Stock price history

Beta (5Y monthly) 0.95
52-week change 3-1.59%
S&P500 52-week change 316.48%
52-week high 3706.95
52-week low 3460.36
50-day moving average 3591.56
200-day moving average 3615.62

Share statistics

Avg vol (3-month) 3430.13k
Avg vol (10-day) 3628.13k
Shares outstanding 584.79M
Implied shares outstanding 6N/A
Float 883.94M
% held by insiders 10.94%
% held by institutions 186.69%
Shares short (13 Jan 2022) 4724.73k
Short ratio (13 Jan 2022) 41.77
Short % of float (13 Jan 2022) 40.97%
Short % of shares outstanding (13 Jan 2022) 40.85%
Shares short (prior month 14 Dec 2021) 4886.02k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 315 Jun 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 24.14%
Operating margin (ttm)29.28%

Management effectiveness

Return on assets (ttm)25.88%
Return on equity (ttm)126.53%

Income statement

Revenue (ttm)3.14B
Revenue per share (ttm)36.73
Quarterly revenue growth (yoy)12.30%
Gross profit (ttm)1.57B
Net income avi to common (ttm)756.86M
Diluted EPS (ttm)8.72
Quarterly earnings growth (yoy)19.80%

Balance sheet

Total cash (mrq)145.2M
Total cash per share (mrq)1.71
Total debt (mrq)963.19M
Total debt/equity (mrq)127.50
Current ratio (mrq)1.48
Book value per share (mrq)8.89

Cash flow statement

Operating cash flow (ttm)764.52M
Levered free cash flow (ttm)568.77M